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Objective
The clinical manifestations of PFAPA syndrome largely
overlap with those of monogenic Autoinflammatory dis-
eases: Familial Mediterranean Fever (FMF), tumor necro-
sis factor (TNF) receptor-associated periodic syndrome
(TRAPS) and Mevalonate kinase deficiency (MKD). Aim
of this study is to evaluate the specificity of the available
diagnostic criteria for PFAPA.
Patients and methods
307 consecutive patients with a clinical history of periodic
fever were screened for mutations of MVK, TNFRSF1A and
MEFV genes and detailed clinical information was col-
lected. PFAPA diagnostic criteria were applied in all these
patients. The clinical parameters associated with an high
risk to be affected by an Autoinflammatory disease were
identified on the basis of a univariate and multivariate
analysis in both genetically positive and negative patients
complying PFAPA criteria.
Results
133 out of 307 patients satisfying PFAPA criteria. 33 car-
ried relevant mutations on the screened genes (27 MKD,
3 TRAPS, 3 FMF), 28 were heterozygous for MEFV muta-
tions, 7 carried R92Q mutation of TNFRSF1A gene, show-
ing the low specificity of current criteria. Rash (OR =
2.975, p = 0.009), abdominal pain (OR = 3.261, p =
0.005) and vomiting (OR = 2.445, p = 0.3) were the vari-
ables most correlated to the positivity at the genetic test.
Conclusion
Current PFAPA criteria display a low specificity. According
to this study, the presence of gastrointestinal manifesta-
tions and skin rash in patients fulfilling the current PFAFA
criteria should orientate towards the exclusion of mono-
genic periodic fevers by molecular analysis. Consistent
modifications of ongoing clinical criteria are proposed.
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